182 related articles for article (PubMed ID: 23071743)
1. A purpose-synthesised anti-fibrotic agent attenuates experimental kidney diseases in the rat.
Gilbert RE; Zhang Y; Williams SJ; Zammit SC; Stapleton DI; Cox AJ; Krum H; Langham R; Kelly DJ
PLoS One; 2012; 7(10):e47160. PubMed ID: 23071743
[TBL] [Abstract][Full Text] [Related]
2. FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy.
Zhang Y; Edgley AJ; Cox AJ; Powell AK; Wang B; Kompa AR; Stapleton DI; Zammit SC; Williams SJ; Krum H; Gilbert RE; Kelly DJ
Eur J Heart Fail; 2012 May; 14(5):549-62. PubMed ID: 22417655
[TBL] [Abstract][Full Text] [Related]
3. FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy.
Deliyanti D; Zhang Y; Khong F; Berka DR; Stapleton DI; Kelly DJ; Wilkinson-Berka JL
PLoS One; 2015; 10(7):e0134392. PubMed ID: 26222724
[TBL] [Abstract][Full Text] [Related]
4. Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy.
Mifsud S; Kelly DJ; Qi W; Zhang Y; Pollock CA; Wilkinson-Berka JL; Gilbert RE
Nephron Physiol; 2003; 95(4):p83-91. PubMed ID: 14694265
[TBL] [Abstract][Full Text] [Related]
5. Root of Polygonum cuspidatum extract reduces progression of diabetes-induced mesangial cell dysfunction via inhibition of platelet-derived growth factor-BB (PDGF-BB) and interaction with its receptor in streptozotocin-induced diabetic rats.
Sohn E; Kim J; Kim CS; Jo K; Lee YM; Kim JS
BMC Complement Altern Med; 2014 Dec; 14():477. PubMed ID: 25495844
[TBL] [Abstract][Full Text] [Related]
6. FT23, an orally active antifibrotic compound, attenuates structural and functional abnormalities in an experimental model of diabetic cardiomyopathy.
Tan SM; Zhang Y; Wang B; Tan CY; Zammit SC; Williams SJ; Krum H; Kelly DJ
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):650-6. PubMed ID: 22612418
[TBL] [Abstract][Full Text] [Related]
7. 3',4'-Bis-difluoromethoxycinnamoylanthranilate (FT061): an orally-active antifibrotic agent that reduces albuminuria in a rat model of progressive diabetic nephropathy.
Williams SJ; Zammit SC; Cox AJ; Shackleford DM; Morizzi J; Zhang Y; Powell AK; Gilbert RE; Krum H; Kelly DJ
Bioorg Med Chem Lett; 2013 Dec; 23(24):6868-73. PubMed ID: 24169234
[TBL] [Abstract][Full Text] [Related]
8. A new anti-fibrotic drug attenuates cardiac remodeling and systolic dysfunction following experimental myocardial infarction.
Zhang Y; Elsik M; Edgley AJ; Cox AJ; Kompa AR; Wang B; Tan CY; Khong FL; Stapleton DI; Zammit S; Williams SJ; Gilbert RE; Krum H; Kelly DJ
Int J Cardiol; 2013 Sep; 168(2):1174-85. PubMed ID: 23219315
[TBL] [Abstract][Full Text] [Related]
9. Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy.
Kelly DJ; Gilbert RE; Cox AJ; Soulis T; Jerums G; Cooper ME
J Am Soc Nephrol; 2001 Oct; 12(10):2098-2107. PubMed ID: 11562408
[TBL] [Abstract][Full Text] [Related]
10. Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-beta.
Martin J; Kelly DJ; Mifsud SA; Zhang Y; Cox AJ; See F; Krum H; Wilkinson-Berka J; Gilbert RE
Cardiovasc Res; 2005 Feb; 65(3):694-701. PubMed ID: 15664396
[TBL] [Abstract][Full Text] [Related]
11. Evaluation and optimization of antifibrotic activity of cinnamoyl anthranilates.
Zammit SC; Cox AJ; Gow RM; Zhang Y; Gilbert RE; Krum H; Kelly DJ; Williams SJ
Bioorg Med Chem Lett; 2009 Dec; 19(24):7003-6. PubMed ID: 19879136
[TBL] [Abstract][Full Text] [Related]
12. The anti-fibrotic hormone relaxin is not reno-protective, despite being active, in an experimental model of type 1 diabetes.
Wong SE; Samuel CS; Kelly DJ; Zhang Y; Becker GJ; Hewitson TD
Protein Pept Lett; 2013 Sep; 20(9):1029-38. PubMed ID: 23343143
[TBL] [Abstract][Full Text] [Related]
13. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis.
Wang SN; Hirschberg R
Am J Physiol Renal Physiol; 2000 Apr; 278(4):F554-60. PubMed ID: 10751215
[TBL] [Abstract][Full Text] [Related]
14. Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
Wang D; Zhang G; Chen X; Wei T; Liu C; Chen C; Gong Y; Wei Q
Int J Mol Med; 2018 May; 41(5):2784-2792. PubMed ID: 29484381
[TBL] [Abstract][Full Text] [Related]
15. Differential and synergistic effects of platelet-derived growth factor-BB and transforming growth factor-beta1 on activated pancreatic stellate cells.
Kordes C; Brookmann S; Häussinger D; Klonowski-Stumpe H
Pancreas; 2005 Aug; 31(2):156-67. PubMed ID: 16025003
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of Armanni-Ebstein lesions in a rat model of diabetes by a new anti-fibrotic, anti-inflammatory agent, FT011.
Lau X; Zhang Y; Kelly DJ; Stapleton DI
Diabetologia; 2013 Mar; 56(3):675-9. PubMed ID: 23242170
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor-BB induces cystathionine γ-lyase expression in rat mesangial cells via a redox-dependent mechanism.
Hassan MI; Boosen M; Schaefer L; Kozlowska J; Eisel F; von Knethen A; Beck M; Hemeida RA; El-Moselhy MA; Hamada FM; Beck KF; Pfeilschifter J
Br J Pharmacol; 2012 Aug; 166(8):2231-42. PubMed ID: 22428706
[TBL] [Abstract][Full Text] [Related]
18. Alpha1beta1 integrin-mediated collagen matrix remodeling by rat mesangial cells is differentially regulated by transforming growth factor-beta and platelet-derived growth factor-BB.
Kagami S; Kondo S; Löster K; Reutter W; Kuhara T; Yasutomo K; Kuroda Y
J Am Soc Nephrol; 1999 Apr; 10(4):779-89. PubMed ID: 10203362
[TBL] [Abstract][Full Text] [Related]
19. Delayed treatment with lithospermate B attenuates experimental diabetic renal injury.
Lee GT; Ha H; Jung M; Li H; Hong SW; Cha BS; Lee HC; Cho YD
J Am Soc Nephrol; 2003 Mar; 14(3):709-20. PubMed ID: 12595507
[TBL] [Abstract][Full Text] [Related]
20. Urocortin 1 improves renal function in rats with streptozotocin-induced diabetes by inhibiting overproduction of TGF-beta 1 and VEGF.
Li X; Hu J; Zhang Q; Sun X; Li S
Br J Pharmacol; 2009 Jul; 157(6):994-1003. PubMed ID: 19466989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
